MedTrace Logo

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models

NCT06002425 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2023-09-08

No results posted yet for this study

Summary

This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.

Conditions

  • Gastrointestinal Neoplasm Malignant

Interventions

OTHER

Clinician-Directed Treatment Plan

In this approach, clinicians do not employ any technological assistance and rely solely on their professional expertise and experience to formulate treatment plans for participants.

OTHER

ChatGPT-Assisted Treatment Plan

In this approach, clinicians utilize the ChatGPT technological tool, formulating treatment plans for participants based on its suggestions and their own professional expertise.

Sponsors & Collaborators

  • ZhuHai Hospital

    collaborator OTHER

  • Fifth Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Jiangmen Central Hospital

    collaborator OTHER

  • Peking University Cancer Hospital (Inner Mongolia Campus)

    collaborator UNKNOWN

  • San Raffaele University Hospital, Italy

    collaborator OTHER

  • University Hospital Magdeburg, Germany

    collaborator UNKNOWN

  • City of Hope Medical Center

    collaborator OTHER

  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • Di Dong, PhD · Institute of Automation, Chinese Academy of Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-29
Primary Completion
2023-09-30
Completion
2028-12-31

Countries

  • United States
  • China
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06002425 on ClinicalTrials.gov